We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva Tops Valeant With $6.8B Cephalon Buy

Law360 (May 2, 2011, 12:10 PM EDT) -- Teva Pharmaceutical Industries Ltd. swooped in to buy Cephalon Inc. on Monday in a $6.8 billion deal that blew the doors off a previously rejected $5.7 billion bid by Valeant Pharmaceuticals...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.